{"id":752094,"date":"2023-04-27T10:08:37","date_gmt":"2023-04-27T14:08:37","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\/"},"modified":"2023-04-27T10:08:37","modified_gmt":"2023-04-27T14:08:37","slug":"prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\/","title":{"rendered":"Prelude Therapeutics to Participate in Three Healthcare\u00a0Investor Conferences in May"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">WILMINGTON, Del., April  27, 2023  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5ee4Y1bzKtMA1utFGDmfeldfuUMLg1vLt7fJbAmRLxei9wpy_fDbdyaCA952HuSzlArHnfh4aFWTT08Du93qaUhr9tgtgPhPnNKH_CI0cEo=\" rel=\"nofollow noopener\" target=\"_blank\">Prelude Therapeutics Incorporated<\/a> (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced that company executives will participate in three upcoming healthcare investment conferences.<\/p>\n<p align=\"justify\">Details are as follows:<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>H. C. Wainwright BioConnect Investor Conference at Nasdaq <\/strong><br \/>\n          <br \/>Kris Vaddi, Ph.D., Chief Executive Officer will participate in a fireside chat on Tuesday, May 2, at 1:30 p.m. ET. The live webcast is available <a href=\"https:\/\/journey.ct.events\/view\/566701f6-8ef2-48ba-b37e-a418d6a804fa\" rel=\"nofollow noopener\" target=\"_blank\">here<\/a>. The Company will also host one-on-one investor meetings during the day.<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>Bank of America Securities 2023 Healthcare Conference <\/strong><br \/>\n          <br \/>Jane Huang, MD, President and Chief Medical Officer and Laurent Chardonnet, Chief Financial Officer, will conduct one-on-one meetings on Wednesday, May 10 and Thursday May 11. Dr. Huang will participate in a fireside chat on May 10 at 4:20 p.m. PT\/7:20 p.m. ET. The live webcast will be available <a href=\"https:\/\/bofa.veracast.com\/webcasts\/bofa\/healthcare2023\/id63eg02.cfm\" rel=\"nofollow noopener\" target=\"_blank\">here<\/a>, and will be available for replay until August 11, 2023.<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">\n          <strong>JMP Securities Life Sciences Conference<br \/><\/strong>Dr. Vaddi and Mr. Chardonnet will conduct one-on-one meetings on Monday, May 15 and Tuesday May 16 and Dr. Vaddi will participate in a fireside chat at 12 noon ET, on May 15. The live webcast is available <a href=\"https:\/\/wsw.com\/webcast\/jmp59\/prld\/1688698\" rel=\"nofollow noopener\" target=\"_blank\">here<\/a> and will be available for replay for 90 days.<\/li>\n<\/ul>\n<p align=\"justify\">\n        <strong>About Prelude Therapeutics<\/strong>\u00a0<br \/>Prelude Therapeutics is a clinical-stage precision oncology company developing innovative drug candidates targeting critical cancer cell pathways. The Company\u2019s diverse pipeline is comprised of highly differentiated, potentially best-in-class or first-in-class proprietary small molecule compounds aimed at addressing clinically validated pathways for\u00a0cancers with selectable underserved patients. Prelude\u2019s pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1, PRT2527, a potent and highly selective CDK9 inhibitor, PRT3645, a next generation CDK4\/6 inhibitor<strong>, <\/strong>and PRT3789, an IV administered, potent and highly selective SMARCA2 degrader.<\/p>\n<p align=\"justify\">For more information, visit our <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=R1ciY5uc3makpuezvB4x8X5tCLv4uBuO93uoJlID_0gbQQqgcMrIwDY5-67F5j5s6jmkvGXp4JXFCcs7n47-Pg==\" rel=\"nofollow noopener\" target=\"_blank\">website<\/a> and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=v5A346AEq17FU8OCxybgguHfrx-KJoUdHSShmKguxLmxR7k7SaK-x28GI9FyTFhOTQ_N3VbYwEyj-7BFq_ZM5dxRgKxc5nAMrPJdV9CN8uE62_v42gvdBu4vc0gjFT9dHg0T-xioswEJhH9h-ZaViQ==\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tspln9_bWRXlCPOijHceYxvSvvlC5P1LlgeaXn52LizE2-a-4FNanKS1x6bCDcE9aqCLLG6vh6etCKDSyhjkGA==\" rel=\"nofollow noopener\" target=\"_blank\">Twitter<\/a>.<\/p>\n<p align=\"left\">\n        <strong>Investor Contact:<\/strong>\u00a0<br \/>Lindsey Trickett\u00a0<br \/>Vice President, Investor Relations\u00a0<br \/>240.543.7970\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=w69EUxxrDFepPdE9q6nlKMft7NnfMKQkTbGghWhLqqAgdyg16BfkiGWnRjhurJ9XsiTtCtiBak5ge0wwHiKZbNBNm4didTbK-Uv_7Smy8wg=\" rel=\"nofollow noopener\" target=\"_blank\">ltrickett@preludetx.com<\/a><\/p>\n<p align=\"left\">\n        <strong>Media Contact:<\/strong>\u00a0<br \/>Helen Shik \u00a0<br \/>Shik Communications \u00a0<br \/>617.510.4373<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3RiQwiAmwtFFdsk_brHgtBFW5rTFj-HEDrCdU75QojXJaUCORl8t8jBT270rWbYQbrU9_hfVqZuC-e3W8YdXQm_SD9myC9KOYqQxlUxOEgl94uCJsuRvcaP_C8afwR7o\" rel=\"nofollow noopener\" target=\"_blank\">Helen@ShikCommunications.com<\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNjM5MiM1NTU5NzUxIzIyMDIzMjM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/Y2U2ZjUxZDAtZjFhNi00MjRhLTg5MTAtYWY5MWU4NTZjMzBkLTEyMTM4NzY=\/tiny\/Prelude-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WILMINGTON, Del., April 27, 2023 (GLOBE NEWSWIRE) &#8212; Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced that company executives will participate in three upcoming healthcare investment conferences. Details are as follows: H. C. Wainwright BioConnect Investor Conference at Nasdaq Kris Vaddi, Ph.D., Chief Executive Officer will participate in a fireside chat on Tuesday, May 2, at 1:30 p.m. ET. The live webcast is available here. The Company will also host one-on-one investor meetings during the day. Bank of America Securities 2023 Healthcare Conference Jane Huang, MD, President and Chief Medical Officer and Laurent Chardonnet, Chief Financial Officer, will conduct one-on-one meetings on Wednesday, May 10 and Thursday May 11. Dr. Huang will participate in a fireside &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Prelude Therapeutics to Participate in Three Healthcare\u00a0Investor Conferences in May&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-752094","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Prelude Therapeutics to Participate in Three Healthcare\u00a0Investor Conferences in May - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prelude Therapeutics to Participate in Three Healthcare\u00a0Investor Conferences in May - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WILMINGTON, Del., April 27, 2023 (GLOBE NEWSWIRE) &#8212; Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced that company executives will participate in three upcoming healthcare investment conferences. Details are as follows: H. C. Wainwright BioConnect Investor Conference at Nasdaq Kris Vaddi, Ph.D., Chief Executive Officer will participate in a fireside chat on Tuesday, May 2, at 1:30 p.m. ET. The live webcast is available here. The Company will also host one-on-one investor meetings during the day. Bank of America Securities 2023 Healthcare Conference Jane Huang, MD, President and Chief Medical Officer and Laurent Chardonnet, Chief Financial Officer, will conduct one-on-one meetings on Wednesday, May 10 and Thursday May 11. Dr. Huang will participate in a fireside &hellip; Continue reading &quot;Prelude Therapeutics to Participate in Three Healthcare\u00a0Investor Conferences in May&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-27T14:08:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNjM5MiM1NTU5NzUxIzIyMDIzMjM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Prelude Therapeutics to Participate in Three Healthcare\u00a0Investor Conferences in May\",\"datePublished\":\"2023-04-27T14:08:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\\\/\"},\"wordCount\":324,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNjM5MiM1NTU5NzUxIzIyMDIzMjM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\\\/\",\"name\":\"Prelude Therapeutics to Participate in Three Healthcare\u00a0Investor Conferences in May - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNjM5MiM1NTU5NzUxIzIyMDIzMjM=\",\"datePublished\":\"2023-04-27T14:08:37+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNjM5MiM1NTU5NzUxIzIyMDIzMjM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNjM5MiM1NTU5NzUxIzIyMDIzMjM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prelude Therapeutics to Participate in Three Healthcare\u00a0Investor Conferences in May\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Prelude Therapeutics to Participate in Three Healthcare\u00a0Investor Conferences in May - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\/","og_locale":"en_US","og_type":"article","og_title":"Prelude Therapeutics to Participate in Three Healthcare\u00a0Investor Conferences in May - Market Newsdesk","og_description":"WILMINGTON, Del., April 27, 2023 (GLOBE NEWSWIRE) &#8212; Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced that company executives will participate in three upcoming healthcare investment conferences. Details are as follows: H. C. Wainwright BioConnect Investor Conference at Nasdaq Kris Vaddi, Ph.D., Chief Executive Officer will participate in a fireside chat on Tuesday, May 2, at 1:30 p.m. ET. The live webcast is available here. The Company will also host one-on-one investor meetings during the day. Bank of America Securities 2023 Healthcare Conference Jane Huang, MD, President and Chief Medical Officer and Laurent Chardonnet, Chief Financial Officer, will conduct one-on-one meetings on Wednesday, May 10 and Thursday May 11. Dr. Huang will participate in a fireside &hellip; Continue reading \"Prelude Therapeutics to Participate in Three Healthcare\u00a0Investor Conferences in May\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-27T14:08:37+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNjM5MiM1NTU5NzUxIzIyMDIzMjM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Prelude Therapeutics to Participate in Three Healthcare\u00a0Investor Conferences in May","datePublished":"2023-04-27T14:08:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\/"},"wordCount":324,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNjM5MiM1NTU5NzUxIzIyMDIzMjM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\/","name":"Prelude Therapeutics to Participate in Three Healthcare\u00a0Investor Conferences in May - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNjM5MiM1NTU5NzUxIzIyMDIzMjM=","datePublished":"2023-04-27T14:08:37+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNjM5MiM1NTU5NzUxIzIyMDIzMjM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNjM5MiM1NTU5NzUxIzIyMDIzMjM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/prelude-therapeutics-to-participate-in-three-healthcare-investor-conferences-in-may\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Prelude Therapeutics to Participate in Three Healthcare\u00a0Investor Conferences in May"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/752094","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=752094"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/752094\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=752094"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=752094"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=752094"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}